TABLE 2.
Angiographic and procedural characteristics
| PES (n=512) | BMS (n=722) | P | |
|---|---|---|---|
| Stented coronary vessel*, n (%) | 0.33 | ||
| Left main | 8 (1) | 9 (1) | |
| Left anterior descending | 225 (37) | 293 (35) | |
| Circumflex | 161 (27) | 209 (25) | |
| Right | 190 (31) | 276 (33) | |
| Coronary artery bypass graft | 20 (0.03) | 45 (5) | |
| Lesion type†, n (%) | 0.02 | ||
| Type A | 16 (2) | 26 (3) | |
| Type B1 | 142 (20) | 245 (26) | |
| Type B2 | 375 (52) | 451 (46) | |
| Type C | 143 (20) | 219 (23) | |
| Periprocedural glycoprotein IIb/IIIa inhibitors, n (%) | 157 (31) | 225 (31) | 0.9 |
| Bifurcation stenting†, n (%) | 110 (15) | 113 (12) | 0.02 |
| Implanted stents/patient, n (mean ± SD) | 1.4±0.7 | 1.4±0.7 | 0.09 |
| Stent diameter ≤2.5 mm‡, n (%) | 187 (27) | 112 (11) | <0.0001 |
| Stent length ≥20 mm‡, n (%) | 304 (43) | 275 (27) | <0.0001 |
| Post-PCI TIMI grade 3 flow§, n (%) | 704 (99) | 939 (100) | 0.1 |
*n=604 for paclitaxel-eluting stent (PES) group, n=832 for bare metal stent (BMS);
†
n=714 for PES, n=971 for BMS;
‡
n=701 for PES, n=1036 for BMS;
§
n=714 for PES, n=939 for BMS. PCI Percutaneous coronary intervention; TIMI Thrombolysis In Myocardial Infarction